Buy Enovis

Logo for stock ENOV (Enovis)

Amount

£
GBP

Latest price

$27.69
(£1.00 = $1.346)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$1.584B

P/E ratio

-1.14

EPS

-$24.355

Beta

1.29

Dividend rate

N/A

Dividend yield

N/A

About

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

CEO

Mr. Damien Mcdonald

Employees

7,367

Sector

Consumer Goods

Company HQ

WILMINGTON, United States of America

Website

News

Logo for news article #0 (Enovis Appoints Oliver Engert as Chief Administrative Officer)

Enovis Appoints Oliver Engert as Chief Administrative Officer

Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative Officer, effective today.

GlobeNewsWire

January 05, 2026

Logo for news article #1 (An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares)

An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares

John Kleckner reported an open market purchase of Enovis Corporation shares on Nov. 25, 2025. Kleckner is the principal accounting officer at Enovis Corporation.

The Motley Fool

December 08, 2025

Logo for news article #2 (Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript)

Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript

Enovis Corporation ( ENOV ) UBS Global Healthcare Conference 2025 November 10, 2025 2:45 PM EST Company Participants Damien McDonald - CEO & Director Phillip Berry - Senior VP & CFO Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division All right. Good afternoon, everyone.

Seeking Alpha

November 10, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2026 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies is an Introducer Appointed Representative of Quint Group Limited and not a lender. Quint Group Limited is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 669450). Monevo Limited is an Appointed Representative of TransUnion International UK Limited. TransUnion is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 737740). Emma Technologies introduces customers first to Quint Group Limited, as a licensed credit broker, who then refers on to Monevo Limited.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.